Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impaired performance in a saccadic tracking task in schizophrenic patients.

F M Reischies1, R D Stieglitz, A Mielewczyk

  • 1Department of Psychiatry, Freie Universität Berlin.

European Archives of Psychiatry and Neurological Sciences
|January 1, 1989
PubMed
Summary

Schizophrenic patients exhibit impaired performance on visuospatial saccade tasks, requiring more time and fixations. This cognitive deficit persists even in partly remitted or chronic states, impacting daily functioning.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

ESMO open·2026
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

ESMO podcast on upper GI cancers: highlights in hepatocellular carcinoma and pancreatic cancer from ESMO 2025.

ESMO gastrointestinal oncology·2026
Same author

Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation-Current Evidence and Future Directions. Authors' reply.

Alimentary pharmacology & therapeutics·2026
Same author

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with m<i>IDH1</i> cholangiocarcinoma.

ESMO gastrointestinal oncology·2026

Area of Science:

  • Neuroscience
  • Psychiatry
  • Ophthalmology

Background:

  • Previous research indicated acute schizophrenic patients require more fixations for visuospatial saccade tasks.
  • Eye movement recording studies highlight oculomotor control deficits in schizophrenia.

Purpose of the Study:

  • To assess the performance of schizophrenic patients in a visuospatial saccade task.
  • To compare performance across different patient states (acute, partly remitted, remitted/mildly chronic) and age groups.
  • To explore correlations between task performance and psychological test batteries.

Main Methods:

  • Utilized a visuospatial saccade task requiring sequential eye movements.
  • Recorded eye movements to quantify performance metrics like fixation count and time.

Related Experiment Videos

  • Compared patient groups (acute, partly remitted, remitted/mildly chronic) with age-matched controls.
  • Administered a clinical psychological test battery to assess cognitive function.

    • Main Results:

    • Schizophrenic patients, including those in partly remitted or remitted/mildly chronic states, performed worse than controls.
    • The 'time score' was a particularly sensitive indicator of this performance deficit.
    • Increased fixation counts were observed in acute schizophrenic patients compared to controls.

    Conclusions:

    • Visuospatial saccade task performance is impaired in schizophrenic patients across various illness states.
    • Oculomotor control deficits, evidenced by increased fixations and time, are a persistent feature of schizophrenia.
    • Findings suggest potential links between neuroleptic medication dosage and task performance, warranting further investigation.